Mitochondrial Genomic Analysis of Late Onset Alzheimer's Disease Reveals Protective Haplogroups H6A1A/H6A1B: The Cache County Study on Memory in Aging

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Ridge, Perry G ^a,b   Maxwell, Taylor J ^c   Corcoran, Christopher D ^d   Norton, Maria C ^d   Tschanz, JoAnn T ^d   O'Brien, Elizabeth ^e   Kerber, Richard A ^e   Cawthon, Richard M ^f   Munger, Ronald G ^d   Kauwe, John S K ^a  

^a BRIGHAM YOUNG UNIVERSITY   (United States)

^b ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^d UTAH STATE UNIVERSITY   (United States)

^e UNIVERSITY OF LOUISVILLE   (United States)

^f UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA;

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENETIC RISK; GENETIC VARIABILITY; GENOME ANALYSIS; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MITOCHONDRIAL GENOME; NEUROPROTECTION; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE SEQUENCE; ONSET AGE; POPULATION RESEARCH; RISK ASSESSMENT; RISK REDUCTION; UNITED STATES;

AGED; AGING; ALZHEIMER DISEASE; DEMOGRAPHY; DNA, MITOCHONDRIAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME, MITOCHONDRIAL; HAPLOTYPES; HUMANS; MALE; MEMORY; RISK FACTORS; UTAH;

EID: 84866443759     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045134     Document Type: Article

References (72)

1. Querfurth HW, LaFerla FM, (2010) Alzheimer's disease. N Engl J Med 362: 329-344.
2. Cruts M, Van Broeckhoven C, (1998) Presenilin mutations in Alzheimer's disease. Hum Mutat 11: 183-190.
3. Janssen JC, Beck JA, Campbell TA, Dickinson A, Fox NC, et al. (2003) Early onset familial Alzheimer's disease: Mutation frequency in 31 families. Neurology 60: 235-239.
4. Carrasquillo MM, Belbin O, Hunter TA, Ma L, Bisceglio GD, et al. (2010) Replication of CLU, CR1, and PICALM associations with alzheimer disease. Arch Neurol 67: 961-964.
5. Jun G, Naj AC, Beecham GW, Wang LS, Buros J, et al. (2010) Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes. Arch Neurol 67: 1473-1484.
6. Corneveaux JJ, Myers AJ, Allen AN, Pruzin JJ, Ramirez M, et al. (2010) Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals. Hum Mol Genet 19: 3295-3301.
7. Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, et al. (2011) Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet 43: 429-435.
8. Lambert JC, Heath S, Even G, Campion D, Sleegers K, et al. (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 41: 1094-1099.
9. Naj AC, Jun G, Beecham GW, Wang LS, Vardarajan BN, et al. (2011) Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet 43: 436-441.
10. Kamboh MI, Minster RL, Demirci FY, Ganguli M, Dekosky ST, et al. (2010) Association of CLU and PICALM variants with Alzheimer's disease. Neurobiol Aging.
11. Cupples LA, Farrer LA, Sadovnick AD, Relkin N, Whitehouse P, et al. (2004) Estimating risk curves for first-degree relatives of patients with Alzheimer's disease: the REVEAL study. Genet Med 6: 192-196.
12. Mosconi L, Berti V, Swerdlow RH, Pupi A, Duara R, et al. (2010) Maternal transmission of Alzheimer's disease: prodromal metabolic phenotype and the search for genes. Hum Genomics 4: 170-193.
13. Edland SD, Silverman JM, Peskind ER, Tsuang D, Wijsman E, et al. (1996) Increased risk of dementia in mothers of Alzheimer's disease cases: evidence for maternal inheritance. Neurology 47: 254-256.
14. Heyman A, Wilkinson WE, Hurwitz BJ, Schmechel D, Sigmon AH, et al. (1983) Alzheimer's disease: genetic aspects and associated clinical disorders. Ann Neurol 14: 507-515.
15. Farrer LA, Myers RH, Connor L, Cupples LA, Growdon JH, (1991) Segregation analysis reveals evidence of a major gene for Alzheimer disease. Am J Hum Genet 48: 1026-1033.
16. Duara R, Lopez-Alberola RF, Barker WW, Loewenstein DA, Zatinsky M, et al. (1993) A comparison of familial and sporadic Alzheimer's disease. Neurology 43: 1377-1384.
17. Honea RA, Swerdlow RH, Vidoni ED, Burns JM, (2011) Progressive regional atrophy in normal adults with a maternal history of Alzheimer disease. Neurology 76: 822-829.
18. Mosconi L, Brys M, Switalski R, Mistur R, Glodzik L, et al. (2007) Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism. Proc Natl Acad Sci U S A 104: 19067-19072.
19. Mosconi L, Mistur R, Switalski R, Brys M, Glodzik L, et al. (2009) Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease. Neurology 72: 513-520.
20. Chan DC, (2006) Mitochondria: dynamic organelles in disease, aging, and development. Cell 125: 1241-1252.
21. Swerdlow RH, Burns JM, Khan SM, (2010) The Alzheimer's disease mitochondrial cascade hypothesis. J Alzheimers Dis 20Suppl 2: S265-279.
22. Santos RX, Correia SC, Wang X, Perry G, Smith MA, et al. (2010) Alzheimer's disease: diverse aspects of mitochondrial malfunctioning. Int J Clin Exp Pathol 3: 570-581.
23. Du H, Guo L, Yan S, Sosunov AA, McKhann GM, et al. (2010) Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model. Proc Natl Acad Sci U S A 107: 18670-18675.
24. Chou JL, Shenoy DV, Thomas N, Choudhary PK, Laferla FM, et al. (2011) Early dysregulation of the mitochondrial proteome in a mouse model of Alzheimer's disease. J Proteomics 74: 466-479.
25. Devi L, Prabhu BM, Galati DF, Avadhani NG, Anandatheerthavarada HK, (2006) Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction. J Neurosci 26: 9057-9068.
26. Anandatheerthavarada HK, Devi L, (2007) Amyloid precursor protein and mitochondrial dysfunction in Alzheimer's disease. Neuroscientist 13: 626-638.
27. Silva DF, Esteves AR, Oliveira CR, Cardoso SM, (2011) Mitochondria: the common upstream driver of amyloid-beta and tau pathology in Alzheimer's disease. Curr Alzheimer Res 8: 563-572.
28. Swerdlow RH, Khan SM, (2004) A "mitochondrial cascade hypothesis" for sporadic Alzheimer's disease. Med Hypotheses 63: 8-20.
29. Swerdlow RH, Khan SM, (2009) The Alzheimer's disease mitochondrial cascade hypothesis: an update. Exp Neurol 218: 308-315.
30. Cho DH, Nakamura T, Fang J, Cieplak P, Godzik A, et al. (2009) S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury. Science 324: 102-105.
31. Pagani L, Eckert A, (2011) Amyloid-Beta interaction with mitochondria. Int J Alzheimers Dis 2011: 925050.
32. Quintanilla RA, Dolan PJ, Jin YN, Johnson GV (2012) Truncated tau and Abeta cooperatively impair mitochondria in primary neurons. Neurobiol Aging 33: 619 e625-635.
33. Chinnery PF, Taylor GA, Howell N, Andrews RM, Morris CM, et al. (2000) Mitochondrial DNA haplogroups and susceptibility to AD and dementia with Lewy bodies. Neurology 55: 302-304.
34. Kruger J, Hinttala R, Majamaa K, Remes AM, (2010) Mitochondrial DNA haplogroups in early-onset Alzheimer's disease and frontotemporal lobar degeneration. Mol Neurodegener 5: 8.
35. Mancuso M, Nardini M, Micheli D, Rocchi A, Nesti C, et al. (2007) Lack of association between mtDNA haplogroups and Alzheimer's disease in Tuscany. Neurol Sci 28: 142-147.
36. Pyle A, Foltynie T, Tiangyou W, Lambert C, Keers SM, et al. (2005) Mitochondrial DNA haplogroup cluster UKJT reduces the risk of PD. Ann Neurol 57: 564-567.
37. Zsurka G, Kalman J, Csaszar A, Rasko I, Janka Z, et al. (1998) No mitochondrial haplotype was found to increase risk for Alzheimer's disease. Biol Psychiatry 44: 371-373.
38. Hudson G, Sims R, Harold D, Chapman J, Hollingworth P, et al. (2012) No consistent evidence for association between mtDNA variants and Alzheimer disease. Neurology.
39. van der Walt JM, Dementieva YA, Martin ER, Scott WK, Nicodemus KK, et al. (2004) Analysis of European mitochondrial haplogroups with Alzheimer disease risk. Neurosci Lett 365: 28-32.
40. Carrieri G, Bonafe M, De Luca M, Rose G, Varcasia O, et al. (2001) Mitochondrial DNA haplogroups and APOE4 allele are non-independent variables in sporadic Alzheimer's disease. Hum Genet 108: 194-198.
41. Fesahat F, Houshmand M, Panahi MS, Gharagozli K, Mirzajani F, (2007) Do haplogroups H and U act to increase the penetrance of Alzheimer's disease? Cell Mol Neurobiol 27: 329-334.
42. Santoro A, Balbi V, Balducci E, Pirazzini C, Rosini F, et al. (2010) Evidence for sub-haplogroup h5 of mitochondrial DNA as a risk factor for late onset Alzheimer's disease. PLoS One 5: e12037.
43. Coskun P, Wyrembak J, Schriner S, Chen HW, Marciniack C, et al. (2011) A mitochondrial etiology of Alzheimer and Parkinson disease. Biochim Biophys Acta.
44. Lakatos A, Derbeneva O, Younes D, Keator D, Bakken T, et al. (2010) Association between mitochondrial DNA variations and Alzheimer's disease in the ADNI cohort. Neurobiol Aging 31: 1355-1363.
45. Maruszak A, Canter JA, Styczynska M, Zekanowski C, Barcikowska M, (2009) Mitochondrial haplogroup H and Alzheimer's disease-is there a connection? Neurobiol Aging 30: 1749-1755.
46. Takasaki S, (2009) Mitochondrial haplogroups associated with Japanese Alzheimer's patients. J Bioenerg Biomembr 41: 407-410.
47. Takasaki S, (2009) Mitochondrial haplogroups associated with Japanese centenarians, Alzheimer's patients, Parkinson's patients, type 2 diabetic patients and healthy non-obese young males. J Genet Genomics 36: 425-434.
48. Chagnon P, Gee M, Filion M, Robitaille Y, Belouchi M, et al. (1999) Phylogenetic analysis of the mitochondrial genome indicates significant differences between patients with Alzheimer disease and controls in a French-Canadian founder population. Am J Med Genet 85: 20-30.
49. Breitner JC, Wyse BW, Anthony JC, Welsh-Bohmer KA, Steffens DC, et al. (1999) APOE-epsilon4 count predicts age when prevalence of AD increases, then declines: the Cache County Study. Neurology 53: 321-331.
50. McKhann G, Drachman D, Folstein M, Katzman R, Price D, et al. (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34: 939-944.
51. The International HapMap Consortium, (2003) The International HapMap Project. Nature 426: 789-796.
52. Jorde LB, (1982) The genetic structure of the Utah Mormons: migration analysis. Hum Biol 54: 583-597.
53. Jorde LB, Morgan K, (1987) Genetic structure of the Utah Mormons: isonymy analysis. Am J Phys Anthropol 72: 403-412.
54. O'Brien E, Rogers AR, Beesley J, Jorde LB, (1994) Genetic structure of the Utah Mormons: comparison of results based on RFLPs, blood groups, migration matrices, isonymy, and pedigrees. Hum Biol 66: 743-759.
55. MITOMAP (2011) MITOMAP: A Human Mitochondrial Genome Database, Available: www.mitomap.org.
56. Skolnick M (1980) The Utah genealogical database: A resource for genetic epidemiology. In: Cairns JLJ, Skolnick M, editors. Banbury Report No 4; Cancer Incidence in Defined Populations. New York: Cold Spring Harbor. 285-297.
57. Thompson JD, Gibson TJ, Higgins DG (2002) Multiple sequence alignment using ClustalW and ClustalX. Curr Protoc Bioinformatics Chapter 2: Unit 2 3.
58. Clement M, Posada D, Crandall KA, (2000) TCS: a computer program to estimate gene genealogies. Mol Ecol 9: 1657-1659.
59. Templeton AR, Maxwell T, Posada D, Stengard JH, Boerwinkle E, et al. (2005) Tree scanning: a method for using haplotype trees in phenotype/genotype association studies. Genetics 169: 441-453.
60. Posada D, Maxwell TJ, Templeton AR, (2005) TreeScan: a bioinformatic application to search for genotype/phenotype associations using haplotype trees. Bioinformatics 21: 2130-2132.
61. Templeton AR, Boerwinkle E, Sing CF, (1987) A cladistic analysis of phenotypic associations with haplotypes inferred from restriction endonuclease mapping. I. Basic theory and an analysis of alcohol dehydrogenase activity in Drosophila. Genetics 117: 343-351.
62. Westfall P, Young SS (1993) Resampling-Based Multiple Testing: Examples and Methods for p-Value Adjustments. New York City, NY: Wiley-Interscience.
63. Nowotny P, Hinrichs AL, Smemo S, Kauwe JS, Maxwell T, et al. (2005) Association studies between risk for late-onset Alzheimer's disease and variants in insulin degrading enzyme. Am J Med Genet B Neuropsychiatr Genet 136B: 62-68.
64. Grupe A, Li Y, Rowland C, Nowotny P, Hinrichs AL, et al. (2006) A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease. Am J Hum Genet 78: 78-88.
65. Li Y, Grupe A, Rowland C, Nowotny P, Kauwe JS, et al. (2006) DAPK1 variants are associated with Alzheimer's disease and allele-specific expression. Hum Mol Genet 15: 2560-2568.
66. Kerber RA, (1995) Method for calculating risk associated with family history of a disease. Genet Epidemiol 12: 291-301.
67. Saxena R, de Bakker PI, Singer K, Mootha V, Burtt N, et al. (2006) Comprehensive association testing of common mitochondrial DNA variation in metabolic disease. Am J Hum Genet 79: 54-61.
68. Herrnstadt C, Elson JL, Fahy E, Preston G, Turnbull DM, et al. (2002) Reduced-median-network analysis of complete mitochondrial DNA coding-region sequences for the major African, Asian, and European haplogroups. Am J Hum Genet 70: 1152-1171.
69. Brandstatter A, Salas A, Niederstatter H, Gassner C, Carracedo A, et al. (2006) Dissection of mitochondrial superhaplogroup H using coding region SNPs. Electrophoresis 27: 2541-2550.
70. Brandt U, (2006) Energy converting NADH:quinone oxidoreductase (complex I). Annu Rev Biochem 75: 69-92.
71. Lin FH, Lin R, Wisniewski HM, Hwang YW, Grundke-Iqbal I, et al. (1992) Detection of point mutations in codon 331 of mitochondrial NADH dehydrogenase subunit 2 in Alzheimer's brains. Biochem Biophys Res Commun 182: 238-246.
72. Khalimonchuk O, Rodel G, (2005) Biogenesis of cytochrome c oxidase. Mitochondrion 5: 363-388.